Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
ESMO Gastrointestinal Oncology|February 6, 2026
The clinical utility of an mGPS and SII combined score in patients with advanced gastric cancer treated with nivolumab monotherapyS Udagawa, A Ooki, H Osumi, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Prognostic nutritional index as a prognostic marker in metastatic esophageal squamous-cell carcinoma treated with immune checkpoint inhibitorK Yoshino, M Tamba, H Osumi, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Clinical efficacy of nivolumab-based therapy for HER2-negative diffuse-type advanced gastric or gastroesophageal junction adenocarcinoma with peritoneal disseminationY Suzuki, K Shimozaki, S Udagawa, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Managing zolbetuximab-induced nausea and vomiting: a proposal for a pragmatic approach in clinical practiceK Shimozaki, A Ooki, Y Yamahata, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Safety and efficacy of first-line nivolumab plus chemotherapy for HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: real-world data analysisK Shimozaki, K Fukuda, A Ooki, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
BevRam-GC01 study protocol: a phase I trial of bevacizumab plus ramucirumab and paclitaxel in advanced gastric cancerT Wakatsuki, T Mashima, N Miyazaki, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Semiquantitative CLDN18 expression and clinical outcomes in patients with CLDN18-positive gastric cancer treated with zolbetuximab plus chemotherapyA Ooki, K Nakano, K Shimozaki, et al.
Pageof 3